NKGen Biotech's market cap is currently ―. The company's EPS TTM is $-4.102; its P/E ratio is -0.27; NKGen Biotech is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -32.97M	$ -635.11K	$ -404.06K	$ -968.95K	$ -731.91K
EBITDA	$ -31.79M	$ -635.11K	$ -404.06K	$ -968.95K	$ -731.91K
Net Income Common Stockholders	$ -33.18M	$ -3.02M	$ 887.57K	$ 4.68M	$ 2.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.80M	$ 635.15K	$ 728.01K	$ 1.26M	$ 1.44M
Total Assets	$ 25.20M	$ 174.37M	$ 173.88M	$ 173.64M	$ 173.80M
Total Debt	$ 20.04M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ 11.24M	$ -635.15K	$ -728.01K	$ -1.26M	$ -1.44M
Total Liabilities	$ 65.84M	$ 5.37M	$ 5.58M	$ 6.23M	$ 11.08M
Stockholders Equity	$ -40.64M	$ 168.99M	$ 168.29M	$ 167.40M	$ 162.72M
Cash Flow	-
Free Cash Flow	$ -13.95M	$ -576.50K	$ -532.05K	$ -182.47K	$ -279.98K
Operating Cash Flow	$ -13.95M	$ -576.50K	$ -532.05K	$ -182.47K	$ -279.98K
Investing Cash Flow	$ -113.38M	$ 568.64K	$ 0.00	-	-
Financing Cash Flow	$ 136.84M	$ -85.00K	$ 0.00	-	-

Currency in USD

NKGen Biotech Earnings and Revenue History

Income Statement >

NKGen Biotech Debt to Assets

Balance Sheet >

NKGen Biotech Cash Flow

Cash Flow >

NKGen Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing